Home › High Blood Pressure › Nebraska › Omaha
High Blood Pressure clinical trials in Omaha, NE
4 studies for High Blood Pressure are looking for participants at sites in and around Omaha (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
RecruitingPhase 3
- Clinical Trial Site, Omaha
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
RecruitingPhase 3
- Quality Clinical Research - Omaha, Omaha
Postpartum Evaluation of Nifedipine and Enalapril for Hypertension
RecruitingPhase 4
- Methodist Women's Hospital, Omaha
Labetalol or Nifedipine for Control of Postpartum Hypertension: A Randomized Controlled Trial
RecruitingPhase 4
- Nebraska Methodist Women's Hospital, Omaha
About High Blood Pressure
High blood pressure (hypertension) develops when blood flows through arteries at higher than normal pressures. It increases the risk for heart disease and stroke.
More about High Blood Pressure on MedlinePlus
High Blood Pressure trials in other cities
- Chicago, IL21 studies
- Boston, MA21 studies
- Dallas, TX15 studies
- Nashville, TN14 studies
- Birmingham, AL12 studies
- Houston, TX11 studies
- Atlanta, GA10 studies
- Durham, NC10 studies
- Tucson, AZ10 studies
- Rochester, MN9 studies
- Philadelphia, PA9 studies
- Miami, FL9 studies
Other studies in Omaha
- Prostate Cancer29 studies
- Non-Small Cell Lung Cancer25 studies
- Breast Cancer23 studies
- Cancer (all types)19 studies
- Colorectal Cancer18 studies
- Multiple Myeloma17 studies
- Ovarian Cancer15 studies
- Pancreatic Cancer15 studies
- Head and Neck Squamous Cell Carcinoma15 studies
- Metastatic Cancer14 studies
- Non-Hodgkin Lymphoma14 studies
- Lung Cancer13 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.